|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Albany Medical College Albany, NY 12208
Any reservations about the potential of sonography to screen for gallbladder carcinoma are certainly justified, particularly given the present health care climate. Polypoid lesions of the gallbladder are a frequent incidental finding at sonography, with prevalence rates reported in the literature as ranging from 4-7% [1, 2]. Most of these lesions are benign cholesterol polyps. Although gallbladder carcinoma may present as a polypoid lesion, this occurrence, fortunately, is exceedingly rare, at least in the United States.
The theoretic rationale for the sonographic follow-up of patients with gallbladder polyps is based on a polyp-to-cancer sequencesimilar to that seen in colon carcinomasin which an adenomatous polyp progresses to a frank gallbladder carcinoma [3]. This sequence is by no means universally accepted, however. Others have suggested that gallbladder carcinomas arise in situ from flat, dysplastic epithelium [4]. Even if one accepts the polyp-to-carcinoma sequence, distinguishing between a benign cholesterol polyp and a potentially premalignant adenoma on the basis of sonographic features is impossible (although multiplicity and increased echogenicity may be indicative of the benign cholesterol polyp).
Size, though, is a useful discriminating feature between benign and malignant polyps: most polypoid gallbladder carcinomas found in patients participating in large-scale cholecystectomy series have been larger than 1 cm [5]. This observation has resulted in the current practice of 6-month or yearly follow-ups of patients with gallbladder polyps smaller than 1 cm. The results of a recent prospective series by Collet et al. [2] together with the anecdotal experience of many sonographers and the epidemiology of gallbladder polyps may make routine polyp surveillance unsupportable. None of the follow-up sonograms performed on 33 and 22 of 38 subjects with gallbladder polyps at 2 and 5 years, respectively, showed any change suggestive of malignant transformation.
Despite these findings, old habits take a long time to break, and when it comes to a disease as dismal as gallbladder carcinoma, it is hard to resist a potential hedge. I currently recommend follow-up sonograms at 6- to 12-month intervals for polyps larger than 5 mm in patients without other potentially life-threatening illnesses. I probably will continue to make this recommendation until appropriately designed large-scale trials and cost-analysis studies say I can do otherwise.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |